Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC) (NCT07367074) | Clinical Trial Compass
CompletedNot Applicable
Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC)
Morocco62 participantsStarted 2026-01-26
Plain-language summary
This study aims to evaluate the effect of an educational intervention on sexual function and therapeutic adherence among women with breast cancer followed in the medical oncology department of Ibn Tofail Hospital, affiliated with Mohammed VI University Hospital Center in Marrakech.
Participants will receive a structured therapeutic education program focusing on breast cancer, available treatments and their potential side effects, as well as treatment adherence and its prognostic significance. Educational sessions will be complemented by patient follow-up to reinforce key messages and support adherence.
The study will assess changes in sexual function and therapeutic adherence before and after the educational intervention.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women aged 18 years and older.
* Diagnosed with breast cancer.
* Receiving oral anticancer treatment.
* Willing to participate in the study.
* Able to attend the educational sessions.
* Having access to a mobile phone (smartphone).
Exclusion Criteria:
* Women with communication disorders.
* Women with severe psychiatric disorders that will interfere with participation in the educational intervention.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on an educational intervention for women with breast cancer and measured changes in sexual function — is addressing sexual health and function something my care team can actively support as part of my overall breast cancer treatment plan?
2Since this trial has already been completed, would my doctor be able to share or point me to any published results about whether the educational program actually improved sexual function scores for participants?
3The trial used the FSFI (Female Sexual Function Index) as its main measurement tool — would it make sense for my doctor to use that same questionnaire to assess how my treatment is affecting my sexual health over time?
4Because this was a non-drug, educational intervention rather than a medication trial, what kinds of educational resources or programs does my doctor already recommend to breast cancer patients dealing with sexual health concerns, and how do they compare to what was studied here?
5Given that this trial is completed and not enrolling, are there any similar ongoing studies or standard-of-care programs my doctor could refer me to if I want support with the sexual health side effects of breast cancer treatment?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Sexual Function Score (FSFI)
Timeframe: Baseline and 2 months after the intervention
Trial details
NCT IDNCT07367074
SponsorInstituts Supérieurs des Professions Infirmières et Techniques de Santé, Morocco